Literature DB >> 19036992

Direct binding with histone deacetylase 6 mediates the reversible recruitment of parkin to the centrosome.

Qian Jiang1, Yong Ren, Jian Feng.   

Abstract

Histone deacetylase 6 (HDAC6), a microtubule-associated tubulin deacetylase, plays a significant role in the formation of protein aggregates in many neurodegenerative disorders. Parkin, a protein-ubiquitin E3 ligase linked to Parkinson's disease, accumulates at the centrosome in a microtubule-dependent manner in response to proteasome inhibition. Here, we show that the centrosome recruitment of parkin was mediated by its direct binding to HDAC6 through multiple interaction domains. The tubulin deacetylase activity of HDAC6 was required for the accumulation of parkin as well as its dispersion upon the reversal of proteasome inhibition. The bidirectional movements of parkin required intact microtubule network and were dependent on dynein and kinesin 1, respectively. Tubulin deacetylation increases microtubule dynamicity and may thus facilitate microtubule-based trafficking of the parkin-HDAC6 complex. The results suggest that HDAC6 acts as a sensor of proteasome inhibition and directs the trafficking of parkin by using different motor proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19036992      PMCID: PMC2680492          DOI: 10.1523/JNEUROSCI.2860-08.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  29 in total

Review 1.  Aggresomes, inclusion bodies and protein aggregation.

Authors:  R R Kopito
Journal:  Trends Cell Biol       Date:  2000-12       Impact factor: 20.808

2.  Parkin stabilizes microtubules through strong binding mediated by three independent domains.

Authors:  Fang Yang; Qian Jiang; Jinghui Zhao; Yong Ren; Mark D Sutton; Jian Feng
Journal:  J Biol Chem       Date:  2005-02-28       Impact factor: 5.157

3.  Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation.

Authors:  Jim P Dompierre; Juliette D Godin; Bénédicte C Charrin; Fabrice P Cordelières; Stephen J King; Sandrine Humbert; Frédéric Saudou
Journal:  J Neurosci       Date:  2007-03-28       Impact factor: 6.167

Review 4.  The tubulin code.

Authors:  Kristen J Verhey; Jacek Gaertig
Journal:  Cell Cycle       Date:  2007-06-26       Impact factor: 4.534

Review 5.  Diagnosis and treatment of Parkinson disease: molecules to medicine.

Authors:  Joseph M Savitt; Valina L Dawson; Ted M Dawson
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

6.  HDAC6 deacetylation of tubulin modulates dynamics of cellular adhesions.

Authors:  Andy Dong-Anh Tran; Timothy P Marmo; Ambar A Salam; Sally Che; Erik Finkelstein; Rafi Kabarriti; Harry S Xenias; Ralph Mazitschek; Charlotte Hubbert; Yoshiharu Kawaguchi; Michael P Sheetz; Tso-Pang Yao; J Chloë Bulinski
Journal:  J Cell Sci       Date:  2007-03-27       Impact factor: 5.285

7.  HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor.

Authors:  Jeffrey J Kovacs; Patrick J M Murphy; Stéphanie Gaillard; Xuan Zhao; June-Tai Wu; Christopher V Nicchitta; Minoru Yoshida; David O Toft; William B Pratt; Tso-Pang Yao
Journal:  Mol Cell       Date:  2005-05-27       Impact factor: 17.970

8.  Microtubule acetylation promotes kinesin-1 binding and transport.

Authors:  Nathan A Reed; Dawen Cai; T Lynne Blasius; Gloria T Jih; Edgar Meyhofer; Jacek Gaertig; Kristen J Verhey
Journal:  Curr Biol       Date:  2006-11-07       Impact factor: 10.834

9.  HDAC6 modulates cell motility by altering the acetylation level of cortactin.

Authors:  Xiaohong Zhang; Zhigang Yuan; Yingtao Zhang; Sarah Yong; Alexis Salas-Burgos; John Koomen; Nancy Olashaw; J Thomas Parsons; Xiang-Jiao Yang; Sharon R Dent; Tso-Pang Yao; William S Lane; Edward Seto
Journal:  Mol Cell       Date:  2007-07-20       Impact factor: 17.970

10.  Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6.

Authors:  James A Olzmann; Lian Li; Maksim V Chudaev; Jue Chen; Francisco A Perez; Richard D Palmiter; Lih-Shen Chin
Journal:  J Cell Biol       Date:  2007-09-10       Impact factor: 10.539

View more
  24 in total

Review 1.  Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs.

Authors:  Kurt R Brunden; Virginia M-Y Lee; Amos B Smith; John Q Trojanowski; Carlo Ballatore
Journal:  Neurobiol Dis       Date:  2016-12-22       Impact factor: 5.996

2.  To prevent neurodegeneration: HDAC6 uses different strategies for different challenges.

Authors:  Guiping Du; Renjie Jiao
Journal:  Commun Integr Biol       Date:  2011-03

3.  TPPP/p25 promotes tubulin acetylation by inhibiting histone deacetylase 6.

Authors:  Natália Tokési; Attila Lehotzky; István Horváth; Bálint Szabó; Judit Oláh; Pierre Lau; Judit Ovádi
Journal:  J Biol Chem       Date:  2010-03-22       Impact factor: 5.157

4.  Parkin ubiquitinates Tar-DNA binding protein-43 (TDP-43) and promotes its cytosolic accumulation via interaction with histone deacetylase 6 (HDAC6).

Authors:  Michaeline L Hebron; Irina Lonskaya; Kaydee Sharpe; Puwakdandawe P K Weerasinghe; Norah K Algarzae; Ashot R Shekoyan; Charbel E-H Moussa
Journal:  J Biol Chem       Date:  2012-12-20       Impact factor: 5.157

5.  HDAC6 regulates mitochondrial transport in hippocampal neurons.

Authors:  Sigeng Chen; Geoffrey C Owens; Helen Makarenkova; David B Edelman
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

Review 6.  The tale of protein lysine acetylation in the cytoplasm.

Authors:  Karin Sadoul; Jin Wang; Boubou Diagouraga; Saadi Khochbin
Journal:  J Biomed Biotechnol       Date:  2010-11-28

Review 7.  An emerging role of PARK2 in cancer.

Authors:  Liang Xu; De-chen Lin; Dong Yin; H Phillip Koeffler
Journal:  J Mol Med (Berl)       Date:  2013-12-03       Impact factor: 4.599

Review 8.  Interactions between inflammation, sex steroids, and Alzheimer's disease risk factors.

Authors:  Mariana F Uchoa; V Alexandra Moser; Christian J Pike
Journal:  Front Neuroendocrinol       Date:  2016-09-17       Impact factor: 8.606

Review 9.  Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease.

Authors:  Dominik Haddad; Ken Nakamura
Journal:  FEBS Lett       Date:  2015-10-23       Impact factor: 4.124

Review 10.  SUMO and Parkinson's disease.

Authors:  Katrin Eckermann
Journal:  Neuromolecular Med       Date:  2013-08-25       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.